title: Long term results in acute non-lymphocytic leukaemia.
authors.forename: T K
authors.initials: TK
authors.lastname: Saikia
authors.forename: A
authors.initials: A
authors.lastname: Rajni
authors.forename: R
authors.initials: R
authors.lastname: Gopal
authors.forename: C N
authors.initials: CN
authors.lastname: Nair
authors.forename: K S
authors.initials: KS
authors.lastname: Nadkarni
authors.forename: P A
authors.initials: PA
authors.lastname: Kurkure
authors.forename: V R
authors.initials: VR
authors.lastname: Pai
authors.forename: S K
authors.initials: SK
authors.lastname: Pai
authors.forename: S H
authors.initials: SH
authors.lastname: Advani
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000628:therapy; D008297:Male
chemical_list: D003561:Cytarabine; D004317:Doxorubicin; D003630:Daunorubicin